| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.007 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |